248 related articles for article (PubMed ID: 33774551)
1. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.
Chen X; Rostad CA; Anderson LJ; Sun HY; Lapp SA; Stephens K; Hussaini L; Gibson T; Rouphael N; Anderson EJ
Virology; 2021 Jul; 559():1-9. PubMed ID: 33774551
[TBL] [Abstract][Full Text] [Related]
2. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
Tso FY; Lidenge SJ; Poppe LK; Peña PB; Privatt SR; Bennett SJ; Ngowi JR; Mwaiselage J; Belshan M; Siedlik JA; Raine MA; Ochoa JB; Garcia-Diaz J; Nossaman B; Buckner L; Roberts WM; Dean MJ; Ochoa AC; West JT; Wood C
PLoS One; 2021; 16(3):e0247640. PubMed ID: 33661923
[TBL] [Abstract][Full Text] [Related]
3. Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.
Hong Y; Guo H; Wei M; Zhang Y; Fang M; Cheng T; Li Z; Ge S; Yao X; Yuan Q; Xia N
J Virol Methods; 2022 Sep; 307():114564. PubMed ID: 35671888
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients.
Yu Y; Wang M; Zhang X; Li S; Lu Q; Zeng H; Hou H; Li H; Zhang M; Jiang F; Wu J; Ding R; Zhou Z; Liu M; Si W; Zhu T; Li H; Ma J; Gu Y; She G; Li X; Zhang Y; Peng K; Huang W; Liu W; Wang Y
Signal Transduct Target Ther; 2021 Sep; 6(1):346. PubMed ID: 34561414
[TBL] [Abstract][Full Text] [Related]
5. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
Front Immunol; 2021; 12():793953. PubMed ID: 34899762
[TBL] [Abstract][Full Text] [Related]
6. A new flow cytometry assay to measure antibody-dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells.
Beaudoin-Bussières G; Richard J; Prévost J; Goyette G; Finzi A
STAR Protoc; 2021 Dec; 2(4):100851. PubMed ID: 34541555
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Dufloo J; Grzelak L; Staropoli I; Madec Y; Tondeur L; Anna F; Pelleau S; Wiedemann A; Planchais C; Buchrieser J; Robinot R; Ungeheuer MN; Mouquet H; Charneau P; White M; Lévy Y; Hoen B; Fontanet A; Schwartz O; Bruel T
Cell Rep Med; 2021 May; 2(5):100275. PubMed ID: 33899033
[TBL] [Abstract][Full Text] [Related]
8. Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.
Díez JM; Romero C; Cruz M; Vandeberg P; Merritt WK; Pradenas E; Trinité B; Blanco J; Clotet B; Willis T; Gajardo R
J Infect Dis; 2022 Mar; 225(6):938-946. PubMed ID: 34693968
[TBL] [Abstract][Full Text] [Related]
9. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.
Natarajan H; Crowley AR; Butler SE; Xu S; Weiner JA; Bloch EM; Littlefield K; Wieland-Alter W; Connor RI; Wright PF; Benner SE; Bonny TS; Laeyendecker O; Sullivan D; Shoham S; Quinn TC; Larman HB; Casadevall A; Pekosz A; Redd AD; Tobian AAR; Ackerman ME
mBio; 2021 Apr; 12(2):. PubMed ID: 33879585
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
[TBL] [Abstract][Full Text] [Related]
11. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
12. Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity.
Cao J; Wang L; Yu C; Wang K; Wang W; Yan J; Li Y; Yang Y; Wang X; Wang J
Sci Rep; 2020 Oct; 10(1):16615. PubMed ID: 33024203
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
14. Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
Markmann AJ; Giallourou N; Bhowmik DR; Hou YJ; Lerner A; Martinez DR; Premkumar L; Root H; van Duin D; Napravnik S; Graham SD; Guerra Q; Raut R; Petropoulos CJ; Wrin T; Cornaby C; Schmitz J; Kuruc J; Weiss S; Park Y; Baric R; de Silva AM; Margolis DM; Bartelt LA
mSphere; 2021 Aug; 6(4):e0027521. PubMed ID: 34431693
[TBL] [Abstract][Full Text] [Related]
15. Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions.
Capuano C; De Federicis D; Ciuti D; Turriziani O; Angeloni A; Anastasi E; Giannini G; Belardinilli F; Molfetta R; Alvaro D; Palmieri G; Galandrini R
Front Immunol; 2023; 14():1285203. PubMed ID: 38045702
[TBL] [Abstract][Full Text] [Related]
16. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
[TBL] [Abstract][Full Text] [Related]
17. High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19.
Vietzen H; Danklmaier V; Zoufaly A; Puchhammer-Stöckl E
Genet Med; 2022 Jul; 24(7):1449-1458. PubMed ID: 35488894
[TBL] [Abstract][Full Text] [Related]
18. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Motsoeneng BM; Manamela NP; Kaldine H; Kgagudi P; Hermanus T; Ayres F; Makhado Z; Moyo-Gwete T; van der Mescht MA; Abdullah F; Boswell MT; Ueckermann V; Rossouw TM; Madhi SA; Moore PL; Richardson SI
Front Immunol; 2023; 14():1231276. PubMed ID: 37600825
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.
Rieke GJ; van Bremen K; Bischoff J; ToVinh M; Monin MB; Schlabe S; Raabe J; Kaiser KM; Finnemann C; Odainic A; Kudaliyanage A; Latz E; Strassburg CP; Boesecke C; Schmidt SV; Krämer B; Rockstroh JK; Nattermann J
J Infect Dis; 2022 May; 225(10):1688-1693. PubMed ID: 35323975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
